![Karyopharm Therapeutics Inc. logo](/logos/KPTI.webp)
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
Overview | Financials
Company Name | Karyopharm Therapeutics Inc. |
Symbol | KPTI |
Currency | USD |
Price | 0.73 |
Market Cap | 91,044,257 |
Dividend Yield | 0% |
52-week-range | 0.617 - 1.95 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Richard A. Paulson M.B.A. |
Website | https://www.karyopharm.com |
An error occurred while fetching data.
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD